HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS- REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

Author(s)

Karampampa K1, Gyllensten H2, Yang F2, Murley C2, Friberg E2, Hillert J2, Alexanderson K2
1Karolinska Institutet, Stockholm, AB, Sweden, 2Karolinska Institutet, Stockholm, Sweden

OBJECTIVES: To explore healthcare, sickness absence (SA), and disability pension (DP) cost trajectories among people with multiple sclerosis (PwMS) following diagnosis, accounting for socioeconomic characteristics and comorbidities. METHODS: All PwMS in Sweden, 25-60 years old at MS diagnosis, according to the National Patient Register, were included. Microdata were linked from several nationwide registers. Four cohorts, based on diagnosis year (2006-2009) were followed prospectively, for 5 years, regarding 1) direct costs: healthcare and out-of-pocket expenditure, and prescribed drugs, and 2) indirect costs: SA and DP. Average per patient costs were calculated, in 2017 Swedish Krona (SEK). A group-based trajectory Poisson model was used, mapping cost progression and assessing heterogeneity based on socioeconomic characteristics (age, gender, education, type of living area, geographic region, country of birth, marital status), and comorbidities at diagnosis year. RESULTS: Five cost trajectories were identified among the 3272 PwMS. One, where 32.2% of PwMS belonged, had high direct and indirect costs, first increasing and then decreasing. This was in line with the average direct costs in the overall study population, increasing the 1st year, and then declining 3 years after (e.g., for the 2009 cohort, from SEK 87,796 to 97,801, and then to 80,394). Another trajectory had low direct and indirect costs, first decreasing and then increasing, possibly explained by the decrease in SA over time and increase in DP, indicating a shift from short-term to long-term social security benefits. A 3rd trajectory, where only 2.4% of PwMS belonged, had high direct and indirect costs, which decreased substantially after 4 years. Finally, the last two trajectories had either high direct or indirect costs. Socioeconomic consequences and comorbidities differed significantly across trajectory groups. CONCLUSIONS: There is heterogeneity across sub-groups of newly diagnosed PwMS; their socioeconomic and health outcomes differ significantly, leading to different cost trajectories over time.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PND35

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×